Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants

David FitzSimons; Guido François; Andrew Hall; Brian McMahon; André Meheus; Alessandro Zanetti; Bernard Duval; Wolfgang Jilg; Wulf Otto Böcher; Sheng Nan Lu; Ulus Akarca; Daniel Lavanchy; Susan Goldstein; Jangu Banatvala; Pierre Van Damme

doi:10.1016/j.vaccine.2005.03.017

Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants

David FitzSimons
, Guido François^*
, Andrew Hall
, Brian McMahon
, André Meheus
, Alessandro Zanetti
, Bernard Duval
, Wolfgang Jilg
, Wulf Otto Böcher
, Sheng Nan Lu
, Ulus Akarca
, Daniel Lavanchy
, Susan Goldstein
, Jangu Banatvala
, Pierre Van Damme

^*Corresponding author for this work

World Health Organization
University of Antwerp
London School of Hygiene and Tropical Medicine
Centers for Disease Control and Prevention
University of Milan
Institut national de santé publique du Québec
University of Regensburg
Johannes Gutenberg University Mainz
Chang Gung Memorial Hospital
Ege University
King's College London

Research output: Contribution to journal › Journal Article › peer-review

134 Scopus citations

Abstract

The long-term efficacy of hepatitis B vaccine, long-term effectiveness of hepatitis B immunisation programmes, immune memory induced by hepatitis B vaccine, current booster policies, and impact of hepatitis B virus mutants on immunisation programmes were reviewed at the Viral Hepatitis Prevention Board (VHPB) meeting in Sevilla, Spain, March 2004. The main focus was on universal vaccination programmes with data being presented from Italy, Saudi Arabia, Singapore, Spain, Taiwan, Thailand, The Gambia, and USA (Alaska).

Original language	English
Pages (from-to)	4158-4166
Number of pages	9
Journal	Vaccine
Volume	23
Issue number	32
DOIs	https://doi.org/10.1016/j.vaccine.2005.03.017
State	Published - 14 07 2005
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Booster policy
HBV mutants
Hepatitis B
Long-term efficacy
Vaccination programmes
Vaccine

Access to Document

10.1016/j.vaccine.2005.03.017

Cite this

FitzSimons, D., François, G., Hall, A., McMahon, B., Meheus, A., Zanetti, A., Duval, B., Jilg, W., Böcher, W. O., Lu, S. N., Akarca, U., Lavanchy, D., Goldstein, S., Banatvala, J., & Van Damme, P. (2005). Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants. Vaccine, 23(32), 4158-4166. https://doi.org/10.1016/j.vaccine.2005.03.017

@article{bcee6c4847584207b3ae7bc0ca06a5fc,

title = "Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants",

abstract = "The long-term efficacy of hepatitis B vaccine, long-term effectiveness of hepatitis B immunisation programmes, immune memory induced by hepatitis B vaccine, current booster policies, and impact of hepatitis B virus mutants on immunisation programmes were reviewed at the Viral Hepatitis Prevention Board (VHPB) meeting in Sevilla, Spain, March 2004. The main focus was on universal vaccination programmes with data being presented from Italy, Saudi Arabia, Singapore, Spain, Taiwan, Thailand, The Gambia, and USA (Alaska).",

keywords = "Booster policy, HBV mutants, Hepatitis B, Long-term efficacy, Vaccination programmes, Vaccine",

author = "David FitzSimons and Guido Fran{\c c}ois and Andrew Hall and Brian McMahon and Andr{\'e} Meheus and Alessandro Zanetti and Bernard Duval and Wolfgang Jilg and B{\"o}cher, \{Wulf Otto\} and Lu, \{Sheng Nan\} and Ulus Akarca and Daniel Lavanchy and Susan Goldstein and Jangu Banatvala and \{Van Damme\}, Pierre",

year = "2005",

month = jul,

day = "14",

doi = "10.1016/j.vaccine.2005.03.017",

language = "英语",

volume = "23",

pages = "4158--4166",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier Ltd",

number = "32",

}

FitzSimons, D, François, G, Hall, A, McMahon, B, Meheus, A, Zanetti, A, Duval, B, Jilg, W, Böcher, WO, Lu, SN, Akarca, U, Lavanchy, D, Goldstein, S, Banatvala, J & Van Damme, P 2005, 'Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants', Vaccine, vol. 23, no. 32, pp. 4158-4166. https://doi.org/10.1016/j.vaccine.2005.03.017

TY - JOUR

T1 - Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants

AU - FitzSimons, David

AU - François, Guido

AU - Hall, Andrew

AU - McMahon, Brian

AU - Meheus, André

AU - Zanetti, Alessandro

AU - Duval, Bernard

AU - Jilg, Wolfgang

AU - Böcher, Wulf Otto

AU - Lu, Sheng Nan

AU - Akarca, Ulus

AU - Lavanchy, Daniel

AU - Goldstein, Susan

AU - Banatvala, Jangu

AU - Van Damme, Pierre

PY - 2005/7/14

Y1 - 2005/7/14

N2 - The long-term efficacy of hepatitis B vaccine, long-term effectiveness of hepatitis B immunisation programmes, immune memory induced by hepatitis B vaccine, current booster policies, and impact of hepatitis B virus mutants on immunisation programmes were reviewed at the Viral Hepatitis Prevention Board (VHPB) meeting in Sevilla, Spain, March 2004. The main focus was on universal vaccination programmes with data being presented from Italy, Saudi Arabia, Singapore, Spain, Taiwan, Thailand, The Gambia, and USA (Alaska).

AB - The long-term efficacy of hepatitis B vaccine, long-term effectiveness of hepatitis B immunisation programmes, immune memory induced by hepatitis B vaccine, current booster policies, and impact of hepatitis B virus mutants on immunisation programmes were reviewed at the Viral Hepatitis Prevention Board (VHPB) meeting in Sevilla, Spain, March 2004. The main focus was on universal vaccination programmes with data being presented from Italy, Saudi Arabia, Singapore, Spain, Taiwan, Thailand, The Gambia, and USA (Alaska).

KW - Booster policy

KW - HBV mutants

KW - Hepatitis B

KW - Long-term efficacy

KW - Vaccination programmes

KW - Vaccine

UR - https://www.scopus.com/pages/publications/20444483260

U2 - 10.1016/j.vaccine.2005.03.017

DO - 10.1016/j.vaccine.2005.03.017

M3 - 文章

C2 - 15964484

AN - SCOPUS:20444483260

SN - 0264-410X

VL - 23

SP - 4158

EP - 4166

JO - Vaccine

JF - Vaccine

IS - 32

ER -

Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this